Deep Tech Startups

Catalera develops biopesticide solutions using patented formulation technology for biological active ingredients. The company offers fungicides, insecticides, and miticides registered for use across consumer, professional, and agricultural applications in the United States.

1 investor

CatAmmon develops nano-ceramic catalysts intended to replace scarce platinum-group metals (PGMs) in applications such as automotive catalytic converters and ammonia cracking for hydrogen production. The company targets emission control systems and alternative energy markets with lower-cost, scalable advanced materials.

1 investor

Category Labs builds high-performance decentralized systems, including Monad, a fully EVM-compatible layer 1 blockchain designed for high throughput, fast block times, single-slot finality, and low hardware requirements. Its team draws on backgrounds in high-frequency trading and low-level systems engineering.

1 investor

CatSci is a contract research and development partner for medicines development, uniting chemistry, bioscience, analytical science, and solid-state development into integrated process development and route optimisation services. It serves large pharma, biotech, and academia clients across drug modalities, operating from sites in the UK and Europe.

1 investor

Causeway Sensors makes a compact device that measures IgG concentration directly from bioreactor samples, providing at-line, real-time data for bioproduction processes. It serves bioprocessing and biomanufacturing teams.

1 investor

Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers. Its lead product, novoleucel, is a minimally invasive cell therapy designed to improve clinical outcomes and survival for late-stage cancer patients.

1 investor

Cebina is an early-stage biotech investor and incubator that funds and de-risks pre-company and startup drug development projects across pre-seed, seed, and Series A stages. It focuses on therapeutic areas including cardiovascular and metabolic diseases, lung fibrosis, cancer immunotherapy, and anti-infectives, and also pursues co-development and licensing partnerships.</parameter> <parameter name="founders">[]

1 investor

Cedana provides infrastructure software that automatically checkpoints, migrates, and resumes live GPU jobs across computing instances to improve throughput, reliability, and performance.

1 investor

CedarDB builds high-performance database systems designed for modern hardware such as multicore processors, memory, and fast storage. Spun off from the Technical University of Munich's Umbra research project in 2024, the company develops database technology for demanding data workloads.

1 investor

Celera Technologies designs custom analog integrated circuit (IC) solutions, using AI-accelerated workflows to replace legacy analog design flows and shorten delivery times. It serves chip and hardware developers seeking custom analog silicon.

1 investor

Celero Communications develops coherent DSP (digital signal processor) technology for high-bandwidth, low-power optical connections used in AI and data center infrastructure. Its platform provides scalable optical links between AI accelerators, servers, and clusters for accelerated computing.

1 investor

Celero Systems is developing an ingestible pill-based platform that monitors cardiac and respiratory vital signs and delivers medication, aiming to monitor, diagnose, and treat life-threatening conditions without wearables or wires. It operates in the digital health and medical device space.

1 investor

Celesta Capital is a venture capital firm that invests in deep tech companies at the forefront of science and engineering, targeting startups enabling mass adoption of emerging technology, improving health outcomes, and transforming large industries.

1 investor

Cell Invent develops human Alzheimer's disease models from reprogrammed patient cells and uses them to build phenotype-based screening methods for drug discovery and development. Its models also support treatment-response assessment, candidate prioritization, and companion diagnostics development for the pharmaceutical and biotech sector.

1 investor

Cella accelerates the natural geologic process that turns carbon dioxide into a mineral by injecting captured atmospheric CO2 into volcanic rock, where mineralization permanently stores it underground. The company provides carbon storage technology designed to scale alongside carbon capture across varied geologic settings.

1 investor

Cellarim produces beauty and skincare ingredients using enzymatic, cell-free synthesis rather than extraction, fermentation, or conventional chemical methods. It positions its enzyme-based approach as a way to make purer, more scalable, and more sustainable cosmetic ingredients.

1 investor

CellBri develops automated instruments and integrated platforms for cell therapy manufacturing, including modular systems and the all-in-one CellFAB One series designed to support production of therapies such as CAR-T, NK cells, and stem cells for biopharma companies and CDMOs globally.

1 investor

Cellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.

1 investor

Cellestial Health is a preclinical-stage biotech developing therapies for Parkinson's disease, with a lead candidate rooted in astrocytic network biology. The company focuses on drug discovery for neurological disease.

1 investor

Cellevate develops Cellevat3d nanofiber-based microcarriers and cell culture systems for upstream bioprocessing, used in viral vector, viral vaccine, and stem cell production by gene therapy and biopharmaceutical organizations. Founded as a spinout from NanoLund and Prof. Lars Montelius's group, the company focuses on commercializing nanofiber cell culture technology.

1 investor

Cellfion develops materials for next-generation energy and water systems, focused on safer, higher-performance alternatives that reduce environmental impact. The company positions its work around sustainability and circular systems aligned with the UN Sustainable Development Goals.

1 investor

CeLLife Technologies develops battery testing and diagnostics technology that enables advanced data collection to assess battery quality, reduce scrapping of good cells, and extend battery life for manufacturers and energy storage operators. Founded as a spin-off from Tampere University, the company serves the battery production industry with a focus on European and global markets.

1 investor

Cellpurics is a contract research organization providing laboratory analysis services (such as real-time qPCR, Western blot, ELISA, flow cytometry, and pathology) and preclinical efficacy and safety testing for drug development. It also offers cosmetics efficacy evaluation, mesenchymal stem cell quality testing, and one-stop non-clinical to clinical services for veterinary drugs and medical devices.

1 investor

Cellular Highways manufactures the Highway1 Cell Sorter, a benchtop instrument for high-throughput cell sorting applications in research. The company serves life science researchers requiring fast, gentle cell sorting with high cell viability.

1 investor